Inventor
Alain D. Baron
Inventor
San Diego, CA, US
Overview
Patents· 31 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds15%
C07CAcyclic or carbocyclic compounds7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C07KPeptides5%
B29CShaping or joining of plastics1%
B29DProducing particular articles from plastics or from substances in a plastic state1%
PatentTitleYear
11,065,215Biguanide compositions and methods of treating metabolic disorders202110,668,031Biguanide compositions and methods of treating metabolic disorders202010,610,500Chemosensory receptor ligand-based therapies202010,603,291Compositions and methods for treating metabolic disorders202010,201,511Compositions and methods for treating metabolic disorders201910,159,658Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk201810,154,972Biguanide compositions and methods of treating metabolic disorders201810,028,923Biguanide compositions and methods of treating metabolic disorders20189,962,344Chemosensory receptor ligand-based therapies20189,901,551'Chemosensory receptor ligand-based therapies'20189,770,422'Compositions and methods for treating metabolic disorders'20179,572,784'Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk'20179,526,741'Chemosensory receptor ligand-based therapies'20169,486,463'Chemosensory receptor ligand-based therapies'20169,480,663'Biguanide compositions and methods of treating metabolic disorders'20169,481,642'Biguanide compositions and methods of treating metabolic disorders'20169,463,170'Chemosensory receptor ligand-based therapies'20169,211,263'Compositions and methods of treating metabolic disorders'20159,133,260'GIP analog and hybrid polypeptides with selectable properties'20159,114,560'Blowing device comprising a nozzle and a supply duct forming an obtuse angle'20159,050,292'Chemosensory receptor ligand-based therapies'20158,895,498'GIP and exendin hybrid polypeptides'20148,828,953'Chemosensory receptor ligand-based therapies'20148,796,338'Biguanide compositions and methods of treating metabolic disorders'20148,497,240'DPP-IV resistant GIP hybrid polypeptides with selectable properties'20138,404,637'GIP analog and hybrid polypeptides with selectable properties'20138,394,765'Methods of treating obesity with two different anti-obesity agents'20138,389,472'Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease'20138,389,473'Treatment of cardiac arrhythmias'20138,263,545'GIP analog and hybrid polypeptides with selectable properties'20127,790,681'Treatment of cardiac arrhythmias with GLP-1 receptor ligands'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2021Based in San Diego, CA, US· patent location history
2012–2016Patents assigned to BARON ALAIN D (11)· patent assignee history
2013–2015Patents assigned to AMYLIN PHARMACEUTICALS LLC (7)· patent assignee history
2013–2015Patents assigned to ASTRAZENECA PHARMACEUTICALS LP (6)· patent assignee history
2014–2019Patents assigned to ELCELYX THERAPEUTICS INC (13)· patent assignee history
2015Based in Octeville sur Mer, FR· patent location history
2020–2021Patents assigned to ANJI PHARMA US LLC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ELCELYX THERAPEUTICS INC | 13 | 2014–2019 |
| BARON ALAIN Dself | 11 | 2012–2016 |
| AMYLIN PHARMACEUTICALS LLC | 7 | 2013–2015 |
| ASTRAZENECA PHARMACEUTICALS LP | 6 | 2013–2015 |
| ANJI PHARMA US LLC | 4 | 2020–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 30 | 2010–2021 |
| Octeville sur Mer, FR | 1 | 2015 |